Assembly Biosciences
ASMB
100 hedge funds and large institutions have $576M invested in Assembly Biosciences in 2019 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 26 reducing their positions, and 20 closing their positions.
183% more capital invested
Capital invested by funds: $204M → $576M (+$372M)
62% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 26
11% more call options, than puts
Call options by funds: $5.19M | Put options by funds: $4.66M
10% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 20
2% more funds holding
Funds holding: 98 → 100 (+2)
0.53% more ownership
Funds ownership: 6.72% → 7.25% (+0.53%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$35.2M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$28.8M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$20.3M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.6M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$11.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$20.1M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$8.91M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.89M |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$3.86M |
| 5 |
CCPM
Cooper Creek Partners Management
New York
|
-$2.34M |
ASMB Hedge Fund Activity: Q4 2019 in Review
100 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2019, worth a combined $576M — up 183% from $204M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new ASMB positions and 20 closed out — a net gain of 2 holders — while 42 added to existing stakes and 26 trimmed.
The largest buyer was EcoR1 Capital, adding an estimated $35.2M. The largest seller was Armistice Capital, cutting an estimated $20.1M.
- 100 institutional investors held Assembly Biosciences (ASMB) as of Q4 2019, up from 98 in Q3 2019.
- Funds reported $576M of Assembly Biosciences stock for Q4 2019, up 183% quarter-over-quarter.
- 22 funds opened new Assembly Biosciences positions in Q4 2019 and 20 closed out, a net change of +2 holders.
- The largest Assembly Biosciences buyer in Q4 2019 was EcoR1 Capital, an estimated $35.2M added.
- The largest Assembly Biosciences seller in Q4 2019 was Armistice Capital, an estimated $20.1M sold.
Based on aggregated 13F filings for Q4 2019.